National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2019 (No. 5) (PB 40 of 2019) (Cth)

PB 40 of 2019

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2019 (No. 5)

National Health Act 1953

___________________________________________________________________________

I, BEN SLADIC, Assistant Secretary, Pharmacy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 100(2) of the National Health Act 1953.

Dated            24 May       2019

BEN SLADIC

Assistant Secretary

Pharmacy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2019 (No. 5).

(2)This Instrument may also be cited as PB 40 of 2019.

1. Commencement

This Instrument commences on 1 June 2019.

1. Amendment of National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011)

Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

Schedule 1       Amendments

1. Schedule 1, Part 1, after entry for Bleomycin in the form Powder for injection containing bleomycin sulfate 15,000 I.U.

insert:

Powder for injection containing bleomycin sulfate 15,000 I.U. in 1 vial Injection Bleomycin for Injection, USP QY MP C6224 C6275 D

1. Schedule 1, Part 1, entry for Pemetrexed in the form Powder for I.V. infusion 100 mg (as disodium)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

Pemetrexed SUN             RA MP C4792 C7195 D

1. Schedule 1, Part 1, entry for Pemetrexed in the form Powder for I.V. infusion 500 mg (as disodium)

omit:

Pemetrexed Sandoz SZ MP C4792 C7195 D

1. Schedule 1, Part 1, entry for Pemetrexed in the form Powder for I.V. infusion 500 mg (as disodium)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

Pemetrexed SUN             RA MP C4792 C7195 D

1. Schedule 1, Part 1, entry for Pemetrexed in the form Powder for I.V. infusion 1 g (as disodium)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

Pemetrexed SUN             RA MP C4792 C7195 D

1. Schedule 3, after details relevant to Responsible Person code PK

insert:

QY Pro Pharmaceuticals Group Pty Ltd 20 605 457 430